background image for GxP Lifeline
GxP Lifeline
  • 2020-bl-thumb-the-next-evolution-in-manufacturing

    The Next Evolution in Manufacturing

    There’s no reason to keep living in the past when it comes to your batch review process. With review by exception, you can accelerate your processes to get product out the door faster. All while reducing frustration in both quality and manufacturing.

    Full story
  • 2020-bl-thumb-data-integrity-and-21-cfr-part-11

    How Harmonizing 21 CFR Part 11 and Data Integrity Delivers Higher Quality Products

    Complying with the many record and data management requirements for 21 CFR Part 11 and data integrity can be daunting. In this article, Matt Brawner, data integrity subject matter expert (SME) at Sequence Inc., explains how companies can integrate Part 11 and data integrity processes to accelerate pathways to approval and deliver higher quality products to market.

    Full story
  • 2020-bl-humb-fda-trending-toward-cloud-technology

    FDA Trending Toward Cloud Technology to Drive Innovation

    The life sciences industry is experiencing a surge of scientific and technology advances. However, there remains a sizeable gap between the discoveries and the technologies needed to translate them into useful therapies. Recently, the U.S. Food and Drug Administration (FDA) introduced a Technology Modernization Action Plan (TMAP) to foster modernization in the life sciences industry in order to more efficiently expedite scientific innovation.

    Full story
  • 2019-bl-thumb-manufacturing-recall-blunders

    Product Recall Prevention and Recovery: 4 Critical Steps

    Even the slightest oversights or errors can lead to product recalls. Learn about the primary causes of recalls, how regulators classify recalls, the four critical steps of recall recovery, and strategies that can help you avoid recalls altogether.

    Full story
[ { "key": "fid#1", "value": ["GxP Lifeline Blog"] } ]